EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE

March 21, 2026 updated by: Dr Ashish Kumar Duggal, Dr. Ram Manohar Lohia Hospital

The use of transcranial direct current stimulation (tDCS) for the management of deficits developed in stroke is a relatively new type of management option. Many of the studies performed using tDCS have focused on improvements noted in hemiplegia as compared to aphasia, which is an equally disabling outcome of strokes. The results of these studies have not been conclusive and concordant with each other.

In aphasia management, the majority of the studies have focused on chronic strokes. Since the use of tDCS is relatively new, the studies have not focused on a particular type of deficit or stroke. Very few studies have focused on the impact of solely using tDCS. Very few studies have focused on acute to subacute strokes. The results of the studies have, nevertheless, been encouraging.

Improvements in aspects of language tested after a single session of tDCS are short-lived. There is an unmet need to probe the utility of repetitive tDCS on aspects of language function in patients who are aphasic due to acute stroke. There is also a paucity of data in the Indian scenario regarding the same.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

28

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • National Capital Territory of Delhi
      • New Delhi, National Capital Territory of Delhi, India, 110001
        • Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aphasic patients with left middle cerebral artery territory Acute Ischemic Stroke
  • Patients between 18-65 years of age.
  • Within 5 days of onset of stroke.

Exclusion Criteria:

  • Patients with malignant Middle Cerebral Artery territory infarcts and previous clinical history of cerebral hemisphere stroke.
  • Patients with history of previous brain surgery or skull defect due to surgery e.g. craniectomy.
  • Patients with epilepsy.
  • Patients with history of significant head trauma in the last 1 month.
  • Patients with documented history of major depression prior to stroke.
  • Patients with alcohol/drug abuse in the past 6 months.
  • Patients with prior significant cognitive impairment.
  • Pacemaker in situ, cochlear implant in situ.
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Anodal tDCS arm (will receive true tDCS)
Will receive true Anodal tDCS
Sham tDCS
Anodal tDCS
Sham Comparator: Sham tDCS arm (will receive Sham stimulation)
Will receive Sham tDCS stimulation
Sham tDCS
Anodal tDCS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Outcome: Difference of change in Accuracy between Anodal tDCS group and Sham tDCS group at 5 days
Time Frame: at 5 days after tDCS
Accuracy is defined as the number of words spoken without the help of a semantic or phonemic cue on the ICMR Picture Naming Test
at 5 days after tDCS
Co-Primary outcome: Difference of change in Reaction Time between Anodal tDCS group and Sham tDCS group at 5 days
Time Frame: at 5 days after tDCS
Reaction times were documented in milliseconds.
at 5 days after tDCS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference of change in Correct Response between Anodal tDCS group and Sham tDCS group at 5 days
Time Frame: at 5 days after tDCS
Correct Response is defined as the total number of words spoken, with or without the help of either a semantic or a phonemic cue on the ICMR Picture Naming Test.
at 5 days after tDCS
Difference of change in PNT Score between Anodal tDCS group and Sham tDCS group at 5 days
Time Frame: at 5 days after tDCS
PNT scores are recorded as per the guidelines of the ICMR Picture Naming Test
at 5 days after tDCS
Difference of change in Accuracy between Anodal tDCS group and Sham tDCS group at 4 weeks
Time Frame: at 4 weeks after tDCS
Accuracy is defined as the number of words spoken without the help of a semantic or phonemic cue on the ICMR Picture Naming Test
at 4 weeks after tDCS
Difference of change in Reaction Time between Anodal tDCS group and Sham tDCS group at 4 weeks
Time Frame: at 4 weeks after tDCS
Reaction times were documented in milliseconds.
at 4 weeks after tDCS
Difference of change in Correct Response between Anodal tDCS group and Sham tDCS group at 4 weeks
Time Frame: at 4 weeks after tDCS
Correct Response is defined as the total number of words spoken, with or without the help of either a semantic or a phonemic cue on the ICMR Picture Naming Test.
at 4 weeks after tDCS
Difference of change in PNT Score between Anodal tDCS group and Sham tDCS group at 4 weeks
Time Frame: at 4 weeks after tDCS
PNT scores are recorded as per the guidelines of the ICMR Picture Naming Test.
at 4 weeks after tDCS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ashish Kumar Duggal, DM (Neurology), Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 31, 2026

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

March 21, 2026

First Submitted That Met QC Criteria

March 21, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 21, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IPD collected throughout the trial will be available from the Principle Investigator upon reasonable request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphasia, Acquired

Clinical Trials on Transcranial Direct Current Stimulation

Subscribe